|
|
|
|
| LEADER |
00000cam a22000007i 4500 |
| 001 |
SCIDIR_on1369150922 |
| 003 |
OCoLC |
| 005 |
20231120010725.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
230208s2023 ne ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d EBLCP
|d UKAHL
|d YDX
|d OCLCQ
|d UKMGB
|d OCLCF
|d N$T
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC2K2059
|2 bnb
|
| 016 |
7 |
|
|a 020802888
|2 Uk
|
| 019 |
|
|
|a 1374590959
|
| 020 |
|
|
|a 0323904157
|q electronic book
|
| 020 |
|
|
|a 9780323904155
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323903905
|
| 020 |
|
|
|z 0323903908
|
| 035 |
|
|
|a (OCoLC)1369150922
|z (OCoLC)1374590959
|
| 050 |
|
4 |
|a RS164
|b .P59 2023
|
| 050 |
|
4 |
|a RC350.C54
|
| 082 |
0 |
4 |
|a 615.321
|2 23/eng/20230208
|
| 245 |
0 |
0 |
|a Phytochemical nanodelivery systems as potential biopharmaceuticals /
|c edited by J. Basilio Heredia, Erick P. Gutierrez-Grijalva, Angel Licea-Claverie, Janet Alejandra Gutierrez-Uribe, Jayanta Kumar Patra.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands ;
|a Oxford, United Kingdom ;
|a Cambridge MA :
|b Elsevier,
|c [2023]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Nanotechnology in biomedicine
|
| 500 |
|
|
|a Includes index.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Intro -- Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals -- Copyright -- Contents -- Contributors -- Preface -- Section 1 Nanomaterials applied to phytochemicals -- Chapter 1 Phytochemicals as potential biopharmaceutical agents -- 1.1 Terpenes -- 1.2 Alkaloids -- 1.3 Phenolic compounds -- 1.4 Glucosinolates -- 1.5 Preclinical studies -- 1.5.1 Terpenes -- 1.5.2 Alkaloids -- 1.5.3 Phenolic compounds -- 1.5.4 Glucosinolates -- 1.6 Clinical studies -- 1.6.1 Terpenes -- 1.6.2 Alkaloids -- 1.6.3 Phenolic compounds -- 1.6.4 Glucosinolates -- 1.7 Conclusions
|
| 505 |
8 |
|
|a Parkinson disease (PD) -- 2.3.1.6 Osteoarthritis -- 2.3.1.7 Chronic kidney diseases -- 2.3.2 Socioeconomic impact -- 2.4 Conclusions and perspectives -- References -- Chapter 3 Nanomaterials -- 3.1 Introduction -- 3.2 Classification and morphology -- 3.2.1 Liposomes -- 3.2.2 Niosomes -- 3.2.3 Dendrimers -- 3.2.4 Polymeric nanoparticles -- 3.2.5 Nanogels -- 3.2.6 Polymersomes -- 3.2.7 Micelles -- 3.2.8 Core-shell structures -- 3.2.9 Other nanoparticles -- 3.2.9.1 Polyelectrolyte complexes -- 3.2.9.2 Nanoemulsions -- 3.3 Synthetic and natural polymer nanostructures
|
| 505 |
8 |
|
|a 3.4 Synthesis of nanostructures by polymerization and copolymerization -- 3.4.1 Preparation methods for polymeric nanoparticles -- 3.4.1.1 Conventional free radical polymerization -- 3.4.1.2 Radical polymerization controlled by reversible addition-fragmentation chain transfer reaction -- 3.4.1.3 Ring-opening polymerization -- 3.4.1.4 Precipitation polymerization -- 3.4.1.5 Emulsion polymerization -- 3.4.1.6 Surfactant-free emulsion polymerization -- 3.4.1.7 Dendrimers preparation -- 3.4.2 Preparation methods for blockcopolymer nanoparticles -- 3.4.2.1 RAFT -- 3.4.2.2 ATRP -- 3.4.2.3 ROP
|
| 505 |
8 |
|
|a 3.4.2.4 Triblock copolymers -- 3.4.2.5 Preparation methods for core-shell polymers -- 3.4.2.6 Preparation methods for polyelectrolytes -- 3.4.3 Preparation methods for nanogels -- 3.5 Synthesis of nanostructures by polymer modification -- 3.5.1 Preparation by chemical bonding of phytochemicals onto polymers -- 3.5.2 Preparation by noncovalent loading of phytochemicals onto functionalized polymers -- 3.5.2.1 Radical functionalization -- 3.6 Preparation of nanostructures by self-assembly -- 3.6.1 Thermodynamic aspects of self-assembly -- 3.6.2 Preparation methods
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on March 23, 2023).
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology.
|
| 650 |
|
0 |
|a Nanocapsules.
|
| 650 |
|
0 |
|a Phytochemicals
|x Therapeutic use.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Biotechnologie pharmaceutique.
|0 (CaQQLa)201-0229592
|
| 650 |
|
6 |
|a Compos�es phytochimiques
|0 (CaQQLa)201-0325163
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a Nanocapsules
|2 fast
|0 (OCoLC)fst01894714
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 650 |
|
7 |
|a Pharmaceutical biotechnology
|2 fast
|0 (OCoLC)fst01060106
|
| 650 |
|
7 |
|a Phytochemicals
|x Therapeutic use
|2 fast
|0 (OCoLC)fst01063239
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Heredia, J. Basilio,
|e editor.
|
| 700 |
1 |
|
|a Guti�errez-Grijalva, Erick P.,
|e editor.
|1 https://isni.org/isni/0000000501127895
|
| 700 |
1 |
|
|a Licea-Claverie, Angel,
|e editor.
|
| 700 |
1 |
|
|a Guti�errez Uribe, Janet Alejandra,
|e editor.
|
| 700 |
1 |
|
|a Patra, Jayanta Kumar,
|e editor.
|1 https://isni.org/isni/0000000495608077
|
| 776 |
0 |
8 |
|i Print version:
|t Phytochemical nanodelivery systems as potential biopharmaceuticals.
|d Amsterdam : Elsevier, 2023
|z 9780323903905
|w (OCoLC)1350639937
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323903905
|z Texto completo
|
